RxDoctor Payments Data

Michael Fracchia, MD

Orthopaedic Surgery · Port Jefferson, NYNPI 1447260070

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $11,350 of the $18,330 with a category attached, or 61.9%. Aesculap Implant Systems, LLC accounts for 69.9% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2021 at $10,175 and has fallen 99.1% since, to $92 in 2025.

$18,330in general payments, 2019–2025

Across 124 payments — averaging $147.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aesculap Implant Systems, LLC$13K
  • Zimmer Biomet$3K
  • Aesculap, Inc.$500
  • Stryker$446
  • Smith+Nephew$389
  • Johnson & Johnson$275
  • plus $588 from 13 others
$100,862in research payments, 2019–2025

Across 14 payments — averaging $7204.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Aesculap Biologics, LLC$101K

What the payments were for

  • Consulting fees$11,35062%
  • Travel & lodging$1,5749%
  • Food & beverage$5,40629%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,330 in reported general payments places this provider in the 70th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024
$473,805
Medicare patients
750
Services billed
35,798

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone93$668
Cephalexin19$458
Naproxen59$302
Meloxicam69$134
Amoxicillin35$58

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Port Jefferson

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →